Spectrum Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$78,104,000 and profit margin reached -772%. Total operating expenses were $81,019,000.
Profit Margin
| 2013 | 155.85M | -62.13M | -39.87% |
|---|---|---|---|
| 2014 | 186.83M | -45.71M | -24.47% |
| 2015 | 162.55M | -50.78M | -31.24% |
| 2016 | 146.44M | -68.51M | -46.78% |
| 2017 | 128.36M | -91.24M | -71.08% |
| 2018 | 109.33M | -120.01M | -109.77% |
| 2019 | 22.61M | -135.38M | -598.66% |
| 2020 | 0 | -171.27M | |
| 2021 | 0 | -158.43M | |
| 2022 | 10.11M | -78.10M | -772.24% |
SPPI Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 10.11M | 0 | 0 | 22.61M | 109.33M | 128.36M | 146.44M | 162.55M | 186.83M | 155.85M |
Cost of revenue | 1.79M | 0 | 0 | 12.00M | 26.75M | 47.21M | 35.84M | 27.68M | 27.03M | 28.58M |
Gross profit | 8.32M | 0 | 0 | 10.60M | 82.57M | 81.14M | 110.60M | 134.86M | 159.79M | 127.27M |
Operating exp. | ||||||||||
Research and development | 42.20M | 87.29M | 109.37M | 79.32M | 94.95M | 65.89M | 58.93M | 50.76M | 69.66M | 46.67M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 81.01M | 147.70M | 169.73M | 140.69M | 213.75M | 177.80M | 172.22M | 175.59M | 191.36M | 166.05M |
Operating income | -72.69M | -147.70M | -169.73M | -144.03M | -131.17M | -96.66M | -61.62M | -40.73M | -31.56M | -38.78M |
Other income (expenses), net | -5.36M | -10.72M | -1.59M | -561K | 11.50M | -11.36M | 238K | -9.64M | -11.96M | 2.14M |
Income before tax | -78.05M | -158.43M | -171.33M | -144.59M | -120.01M | -108.02M | -70.82M | -50.37M | -43.53M | -36.63M |
Income tax expense | 46K | 4K | -60K | -9.20M | 1K | -16.77M | -2.31M | 406K | 2.18M | 25.49M |
Net income | -78.10M | -158.43M | -171.27M | -135.38M | -120.01M | -91.24M | -68.51M | -50.78M | -45.71M | -62.13M |
Earnings per share | ||||||||||
Basic EPS | -0.43 | -1.02 | -1.38 | -1.22 | -1.16 | -1.07 | -0.94 | -0.78 | -0.71 | -1.02 |
Diluted EPS | -0.43 | -1.02 | -1.38 | -1.22 | -1.16 | -1.07 | -0.94 | -0.78 | -0.71 | -1.02 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |